Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Chronic HCV Genotype 4
NCT01197157Phase 3Completed
- Sponsor
- National Liver Institute
- Start
- Sep 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in hepatitis C (HCV), sponsored by National Liver Institute. Started Sep 2010; status: completed.
02
Drugs
nitazoxanide
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01197157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01197157.